Novel PDGFRA mutation in blastic plasmacytoid dendritic cell neoplasm; possible therapeutic implications
Br J Haematol
.
2022 Apr;197(1):8.
doi: 10.1111/bjh.18008.
Epub 2022 Feb 10.
Authors
Rami Abdulbaki
1
,
Peter A DeRosa
2
,
Dalia Mobarek
3
,
Min-Ling Liu
4
5
,
Victor E Nava
4
5
Affiliations
1
Department of Pathology, The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, USA.
2
Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
3
Department of Medicine, The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, USA.
4
Department of Pathology and Laboratory Medical Service, Veterans Health Administration, Washington, District of Columbia, USA.
5
Department of Pathology, The George Washington Hospital, Washington, District of Columbia, USA.
PMID:
35141948
DOI:
10.1111/bjh.18008
No abstract available
MeSH terms
Dendritic Cells
Hematologic Neoplasms* / genetics
Humans
Mutation
Myeloproliferative Disorders* / genetics
Myeloproliferative Disorders* / therapy
Skin Neoplasms* / therapy